FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 57 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2017. The put-call ratio across all filers is 21.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $8,000 | -76.5% | 2,427 | -78.4% | 0.00% | – |
Q3 2019 | $34,000 | +1600.0% | 11,253 | +1025.3% | 0.00% | – |
Q2 2019 | $2,000 | -77.8% | 1,000 | -58.6% | 0.00% | – |
Q1 2019 | $9,000 | -99.9% | 2,413 | -99.9% | 0.00% | -100.0% |
Q4 2018 | $6,222,000 | +15075.6% | 1,732,997 | +24229.6% | 0.00% | – |
Q3 2018 | $41,000 | +64.0% | 7,123 | +44.3% | 0.00% | – |
Q2 2018 | $25,000 | +400.0% | 4,936 | +393.6% | 0.00% | – |
Q1 2018 | $5,000 | -37.5% | 1,000 | -22.9% | 0.00% | – |
Q4 2017 | $8,000 | -76.5% | 1,297 | -78.3% | 0.00% | – |
Q3 2017 | $34,000 | +580.0% | 5,967 | +496.7% | 0.00% | – |
Q2 2017 | $5,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2017 | $5,000 | -72.2% | 1,000 | -38.1% | 0.00% | – |
Q4 2016 | $18,000 | -28.0% | 1,615 | -38.6% | 0.00% | – |
Q3 2016 | $25,000 | +177.8% | 2,629 | +78.0% | 0.00% | – |
Q2 2016 | $9,000 | -59.1% | 1,477 | -55.4% | 0.00% | – |
Q1 2016 | $22,000 | +46.7% | 3,311 | +86.5% | 0.00% | – |
Q4 2015 | $15,000 | +36.4% | 1,775 | +23.1% | 0.00% | – |
Q3 2015 | $11,000 | -88.9% | 1,442 | -85.1% | 0.00% | – |
Q2 2015 | $99,000 | +280.8% | 9,652 | +237.8% | 0.00% | – |
Q1 2015 | $26,000 | – | 2,857 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 4,781,708 | $28,738,000 | 4.90% |
DSC Advisors, L.P. | 1,187,604 | $7,138,000 | 4.14% |
Opaleye Management Inc. | 960,000 | $5,769,000 | 1.85% |
DAFNA Capital Management LLC | 352,741 | $2,120,000 | 1.14% |
Vivo Capital, LLC | 855,000 | $5,139,000 | 1.10% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 382,838 | $2,301,000 | 0.81% |
SENZAR ASSET MANAGEMENT, LLC | 377,397 | $2,268,000 | 0.58% |
Sio Capital Management, LLC | 131,200 | $789,000 | 0.44% |
Perceptive Advisors | 1,117,324 | $6,715,000 | 0.22% |
Tekla Capital Management LLC | 930,398 | $5,592,000 | 0.22% |